Parallax Volatility Advisers
AGIO icon

Parallax Volatility Advisers’s Agios Pharmaceuticals AGIO Stock Holding History

Parallax Volatility Advisers’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,000
Closed -$590K – 2670
2022
Q4 		$590K Sell
21,000
-42,600
-67% -$1.2M ﹤0.01% 1836
2022
Q3 		$1.8M Buy
63,600
+43,300
+213% +$1.16M ﹤0.01% 1478
2022
Q2 		$451K Buy
+20,300
New +$459K ﹤0.01% 1944
2021
Q3 		– Sell
-61,400
Closed -$3.38M – 2947
2021
Q2 		$3.38M Buy
+61,400
New +$3.43M ﹤0.01% 1427
2020
Q3 		– Sell
-45,000
Closed -$2.41M – 3012
2020
Q2 		$2.41M Buy
+45,000
New +$2.08M ﹤0.01% 1399

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Parallax Volatility Advisers's AGIO Position: Q2 2024 in Review

Parallax Volatility Advisers sold out of Agios Pharmaceuticals (AGIO) in Q2 2024, closing a stake of 48,434 shares — an estimated $1.42M sold.

Parallax Volatility Advisers first reported a position in AGIO in Q3 2017 and held it in 11 quarters. The position peaked at $3.04M in Q2 2022. 206 funds tracked by Wall St. Rank hold AGIO as of Q2 2024.

  • Parallax Volatility Advisers reported no remaining Agios Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 48,434 Agios Pharmaceuticals shares in Q2 2024, an estimated $1.42M.
  • Parallax Volatility Advisers first reported a position in Agios Pharmaceuticals in Q3 2017 and held it in 11 quarters.
  • Parallax Volatility Advisers's Agios Pharmaceuticals position peaked at $3.04M in Q2 2022.
  • 206 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2024.

Based on Parallax Volatility Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.